Lactobacillus reuteristrains reduce incidence and severity of experimental necrotizing enterocolitis via modulation of TLR4 and NF-κB signaling in the intestine
- 15 March 2012
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Gastrointestinal and Liver Physiology
- Vol. 302 (6), G608-G617
- https://doi.org/10.1152/ajpgi.00266.2011
Abstract
Necrotizing enterocolitis (NEC) is the leading gastrointestinal cause of mortality and morbidity in the premature infant. Premature infants have a delay in intestinal colonization by commensal bacteria and colonization with potentially pathogenic organisms. Lactobacillus reuteri is a probiotic that inhibits enteric infections, modulates the immune system, and may be beneficial to prevent NEC. In previous studies, L. reuteri strains DSM 17938 and ATCC PTA 4659 differentially modulated inflammation in vitro; however, the strains had equivalent anti-inflammatory responses in LPS feeding-induced ileitis in neonatal rats in vivo. The impact of these two strains in the prevention of NEC has not been previously investigated. NEC was induced in newborn rats by orogastric formula feeding and exposure to hypoxia. L. reuteri was added to the formula to prevent NEC. NEC score, Toll-like receptor (TLR)-signaling genes, phospho-IκB activity, and cytokine levels in the intestine were examined. Both strains significantly increased survival rate and decreased the incidence and severity of NEC, with optimal effects from DSM 17938. In response to probiotic, mRNA expression of IL-6, TNF-α, TLR4, and NF-κB was significantly downregulated, while mRNA levels of anti-inflammatory cytokine IL-10 were significantly upregulated. In parallel, L. reuteri treatment led to decrease intestinal protein levels of TLR4 and cytokine levels of TNF-α and IL-1β in newborn rats with NEC. Both strains significantly inhibited not only intestinal LPS-induced phospho-IκB activity in an ex vivo study but also decreased the levels of phospho-IκB in the intestines of NEC rat model. Cow milk formula feeding produced a similar but milder proinflammatory profile in the intestine that was also ameliorated by 17938. Our studies demonstrate that each of the two L. reuteri strains has potential therapeutic value in our NEC model and in enteritis associated with cow milk feeding. These results support the concept that L. reuteri may represent a valuable treatment to prevent NEC.Keywords
This publication has 58 references indexed in Scilit:
- Necrotizing EnterocolitisThe New England Journal of Medicine, 2011
- Bifidobacterium bifidum reduces apoptosis in the intestinal epithelium in necrotizing enterocolitisAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2010
- Human-derived probiotic Lactobacillus reuteri strains differentially reduce intestinal inflammationAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2010
- A Catalog of Reference Genomes from the Human MicrobiomeScience, 2010
- Changes in intestinal Toll-like receptors and cytokines precede histological injury in a rat model of necrotizing enterocolitisAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2009
- 16S rRNA gene-based analysis of fecal microbiota from preterm infants with and without necrotizing enterocolitisThe ISME Journal, 2009
- Lactobacillus bulgaricus Prevents Intestinal Epithelial Cell Injury Caused by Enterobacter sakazakii -Induced Nitric Oxide both In Vitro and in the Newborn Rat Model of Necrotizing EnterocolitisInfection and Immunity, 2009
- Toll-Like Receptor Prestimulation Increases Phagocytosis ofEscherichia coliDH5α andEscherichia coliK1 Strains by Murine Microglial CellsInfection and Immunity, 2009
- Removal of Antibiotic Resistance Gene-Carrying Plasmids from Lactobacillus reuteri ATCC 55730 and Characterization of the Resulting Daughter Strain, L . reuteri DSM 17938Applied and Environmental Microbiology, 2008
- Human-derived probiotic Lactobacillus reuteri demonstrate antimicrobial activities targeting diverse enteric bacterial pathogensAnaerobe, 2008